Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
LEP Biomedical Gains Funding for HyaGuard Platform
LEP Biomedical announced pre-seed funding of €100,000 ($107,000) over two 6-month periods, which the company says will allow for further preclinical milestones in the development of the HyaGuard platform. The funding was made through Enterprise Ireland. Innovative Design of HyaGuard…
SalioGen Picks SGT-1001 for Stargardt Disease Development
SalioGen Therapeutics announced the selection of SGT-1001 as a development candidate for Stargardt disease treatment, a rare inherited retinal disease. This innovative therapy, SGT-1001, is designed as a one-time, non-viral intervention aimed at slowing or halting the progressive central vision…
Phoenix-Micron Teams with ArtiKode for AI Imaging
Phoenix-Micron announced a new collaboration with ArtiKode Intelligence, a pioneering artificial intelligence (AI) and machine learning company based in Valencia, Spain. This partnership aims to advance the capabilities of the MICRON Software Suite through automated optical coherence tomography (OCT) segmentation…
Ocugen Completes Dosing in Key Trial for GA Treatment
Ocugen has officially completed dosing in the second cohort of its phase 1/2 ArMaDa trial of OCU410, a novel gene therapy designed to treat geographic atrophy (GA). The therapy, known as adeno-associated viral vector 5 human RORA (AAV5-hRORA), is being…
A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial – Frontiers
A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial Frontiers Source: Author: | Date: 2024-04-23 07:00:00 Source: Author: | Date: 2024-04-23 07:00:00
10 Organizations Making a Difference in Eye Health
In the vast and complex world of healthcare, eye health often doesn’t receive as much attention as it should, despite being crucial to our quality of life. Vision problems and blindness significantly affect millions of people globally, hindering education, employment,…
New Treatment Slows Down Progression of AMD, RP
A breakthrough study has unveiled a promising advancement in the treatment of incurable eye diseases such as age-related macular degeneration and retinitis pigmentosa. Researchers have successfully integrated anti-inflammatory drugs into a hydrogel, aiming to combat inflammation in the retina while…
iHealthScreen Wins US Patent for Glaucoma AI Tool
iHealthScreen has been granted a full US patent for its iPredict glaucoma detection model by the US Patent and Trademark Office (USPTO) as of March 26, 2024. This advanced model leverages AI and color fundus imaging to provide swift and…
Gemini and Bard Excel in Ophthalmology Board Exam
In a recent paper published in the journal Eye, Canadian researchers have evaluated the capabilities of two artificial intelligence chatbots, Google Gemini and Bard, in the ophthalmology board examination. They found that both AI tools achieved acceptable accuracy levels and…
Ocular Therapeutix Reports Promising Axpaxli Results in DR Study
Ocular Therapeutix announced positive topline results from its phase 1 HELIOS study, which evaluated the safety, tolerability, and efficacy of Axpaxli versus a sham control in patients with moderately severe to severe nonproliferative diabetic retinopathy (NPDR) without diabetic macular edema…